Axcelis EVP sells 1,161 shares in open market
Axcelis Technologies executive vice president Gerald M. Blumenstock sold 1,161 shares of common stock in an open-market transaction at $152.70 per share on May 21, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Axcelis Technologies executive vice president Gerald M. Blumenstock sold 1,161 shares of common stock in an open-market transaction at $152.70 per share on May 21, 2026. After this sale, a total of 20,493 shares are reported as issuable upon vesting of restricted stock units granted under the 2012 Equity Incentive Plan and remain subject to forfeiture.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,161 | $152.70 | $177K |
Footnotes (1)
- F1. Of the shares held after this sale on May 21, 2026, 20,493 shares were issuable on vesting of restricted stock units granted to the reporting person under the 2012 Equity Incentive Plan and are subject to forfeiture.
Key Figures
Key Terms
open-market sale financial
restricted stock units financial
2012 Equity Incentive Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Axcelis (ACLS) report for Gerald M. Blumenstock?
What are Gerald M. Blumenstock’s reported Axcelis (ACLS) holdings after this transaction?
What role does Gerald M. Blumenstock hold at Axcelis (ACLS)?
AI-generated analysis. How Rhea-AI works. Not financial advice.